Indianapolis, IN (Oct. 17)-Eli Lilly and Company agreed to acquire ICOS Corporation (Bothell, WA) for $2.1 billion.
Indianapolis, IN (Oct. 17)-Eli Lilly and Company (www.lilly.com) agreed to acquire ICOS Corporation (Bothell, WA, www.icos.com) for $2.1 billion.
The companies have partnered since 1998 in Lilly ICOS LLC, a joint venture that manufactures, markets and sells “Cialis” (tadalafil), an oral PDE-5 inhibitor. Cialis had global sales of $465 million in the first half of 2006.
The deal is expected to close in late 2006 or early 2007.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.